FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Subrin Philippe 2. Date of Event Requiring Statement (Month/Day/Year) 04/15/2011 3. Issuer Name and Ticker or Trading Symbol STAAR SURGICAL CO [STAA] (Last) (First) (Middle) 1911 WALKER AVENUE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Vice President, Switzerland Op 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) MONROVIA, CA 91016 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock (1) 41,500 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options	  (2)	02/26/2014	Common Stock	15,000	$ 7.86	D	Â
Common Stock Options	  (2)	04/06/2015	Common Stock	13,334	$ 3.95	D	Â
Common Stock Options	  (2)	04/01/2017	Common Stock	15,000	$ 5.39	D	Â
Common Stock Options	  (2)	02/13/2018	Common Stock	35,000	$ 2.3	D	Â
Common Stock Options	  (3)	12/14/2020	Common Stock	25,000	$ 5.68	D	Â
Common Stock Options	  (4)	03/14/2021	Common Stock	20,000	$ 5.49	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Subrin Philippe 1911 WALKER AVENUE MONROVIA, CA 91016	Â	Â	  Vice President, Switzerland Op	Â

Signatures

/s/Charles Kaufman as Attorney-in-Fact for Philippe Subrin		08/19/2011
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes (i) 4,000 restricted shares of common stock, subject to forfeiture and vesting in a single installment on March 2, 2012, and (ii) 7,500 Performance Accelerated Restricted Shares of Common Stock (PARS), subject to forfeiture and vesting in a single installment on March 15, 2014, but subject to accelerated vesting as to 1/3 of the shares each year pursuant to achievement of certain performance criteria.
(2)	Fully vested and exercisable as of the date of this report.
(3)	8,333 options will vest on December 15, 2011, 8,333 options will vest on December 15, 2012, and the remaining 8,334 options will vest on December 15, 2013.
(4)	6,666 options will vest 3/15/12, 6,667 options will vest on 3/15/13, and the remaining 6,667 shares will vest on 3/15/14.
  Remarks: This Statement on Form 3 lists Mr. Subrin's holdings of STAAR Surgical Company Non-Derivative and Derivative Securities as of the date he became subject to Section 16(a) of the Securities Exchange Act  of 1934 and the date of this Statement.  It does not reflect any transactions in securities of STAAR Surgical Company.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.